Related references
Note: Only part of the references are listed.Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
Douglas G. Altman et al.
BMC MEDICINE (2012)
Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
Dharanija Madhavan et al.
CLINICAL CANCER RESEARCH (2012)
Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
Ke-Hung Tsui et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Manuel Valladares-Ayerbes et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis
Matjaz Rokavec et al.
MOLECULAR CELL (2012)
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease
Samuel N. Breit et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) Decreases Food Intake, Body Weight and Improves Glucose Tolerance in Mice on Normal & Obesogenic Diets
Laurence Macia et al.
PLOS ONE (2012)
Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Slows Cancer Development but Increases Metastases in TRAMP Prostate Cancer Prone Mice
Yasmin Husaini et al.
PLOS ONE (2012)
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Muller Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside
Xinye Xu et al.
BIOMARKERS (2011)
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
U. Wallin et al.
BRITISH JOURNAL OF CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Gastric cancer - The role of matrix metalloproteinases in tumor progression
Marta Lukaszewicz-Zajac et al.
CLINICA CHIMICA ACTA (2011)
Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer
Anne Cathrine Staff et al.
CLINICAL CANCER RESEARCH (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
Philip A. Gregory et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
Manav Korpal et al.
NATURE MEDICINE (2011)
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2011)
Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer
R. J. E. Skipworth et al.
BRITISH JOURNAL OF CANCER (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2010)
Elevated Serum Matrix Metalloproteinase-3 and-7 in H. pylori-Related Gastric Cancer Can Be Biomarkers Correlating with a Poor Survival
Yi-Chun Yeh et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer
Anne Cathrine Staff et al.
GYNECOLOGIC ONCOLOGY (2010)
Divergent Molecular Mechanisms Underlying the Pleiotropic Functions of Macrophage Inhibitory Cytokine-1 in Cancer
Murielle Mimeault et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Gene Expression Atlas at the European Bioinformatics Institute
Misha Kapushesky et al.
NUCLEIC ACIDS RESEARCH (2010)
MMP-7 overexpression is an independent prognostic marker in gastric cancer
Selja Koskensalo et al.
TUMOR BIOLOGY (2010)
Inflammation A driving force speeds cancer metastasis
Yadi Wu et al.
CELL CYCLE (2009)
Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers
Kyoung Eun Baek et al.
CLINICA CHIMICA ACTA (2009)
Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer
David A. Brown et al.
CLINICAL CANCER RESEARCH (2009)
Identification of Macrophage Inhibitory Cytokine-1 in Adipose Tissue and Its Secretion as an Adipokine by Human Adipocytes
Qi Ding et al.
ENDOCRINOLOGY (2009)
Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome
Sophie Shnaper et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
Roopali Roy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Macrophage Inhibitory Cytokine-1 Is Overexpressed in Malignant Melanoma and Is Associated with Tumorigenicity
Glen M. Boyle et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells
Kwang-Kyu Kim et al.
CARCINOGENESIS (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1) inversely correlates with tumor progression in gastric adenomas and carcinomas
J. Y. Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1
Heiko Johnen et al.
NATURE MEDICINE (2007)
A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Aberrant neuropepticle Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis
KK Rasiah et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers
J Koopmann et al.
CLINICAL CANCER RESEARCH (2004)
Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression
JL Luo et al.
CANCER CELL (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Prediction of mammalian microRNA targets
BP Lewis et al.
CELL (2003)
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
JB Welsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Change in gene expression subsequent to induction of Pnn/DRS/memA:: increase in p21cip1/waf1
YJ Shi et al.
ONCOGENE (2001)
Share Paper
